Economic Burden and Risk of Cardiovascular Disease and Diabetes in Patients with Different Cardiometabolic Risk Profiles
- 1 January 2007
- journal article
- Published by Elsevier BV in Value in Health
- Vol. 10, S12-S20
- https://doi.org/10.1111/j.1524-4733.2006.00150.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the U.S.Diabetes Care, 2005
- The Metabolic Syndrome: Time for a Critical AppraisalDiabetes Care, 2005
- The metabolic syndrome—a new worldwide definitionThe Lancet, 2005
- Interaction of Body Mass Index and Framingham Risk Score in Predicting Incident Coronary Disease in FamiliesCirculation, 2005
- A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)Diabetologia, 2004
- Description and validation of a Markov model of survival for individuals free of cardiovascular disease that uses Framingham risk factorsBMC Medical Informatics and Decision Making, 2004
- Blood Pressure Lowering and Life Expectancy Based on a Markov Model of Cardiovascular EventsHypertension, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Expected gains in life expectancy from various coronary heart disease risk factor modifications.Circulation, 1991
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991